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Introduction: Research into amyotrophic lateral sclerosis often focuses on the purely medical aspects of the disease, without 
paying attention to patient’s experience, suffering and difficulties they face on a daily basis. The aims of this study were 
to describe resilience and investigate its relationship with psychological well-being, measured as depression and anxiety in 
a sample of adult patients with different levels of amyotrophic lateral sclerosis severity. Methods: This was a cross-sectional 
study conducted in Sardinia (Italy). The study took place between January 2017 and June 2017. Thirty-one amyotrophic 
lateral sclerosis patients (55% males; mean age = 63.8 years; standard deviation, SD = 9.6) were included in the study. 
They were recruited from one of the main regional centres for amyotrophic lateral sclerosis treatment on the island, and 
represented the total population of amyotrophic lateral sclerosis patients in the territory in question. Their age ranged from 
37 to 81 years (M = 63.81; SD = 9.63). Assisted by the staff, they completed the Connor–Davidson Resilience Scale and the 
Hospital Anxiety and Depression Scale. Results: A significant, strongly negative correlation was found between resilience 
and psychological well-being. Moreover, the level of depression decreased with the increasing time after the diagnosis, but it 
increased with patient’s age. Conclusions: In view of the results obtained, it can be hypothesised that proper psychological 
support designed to promote the activation of resilience resources could help an amyotrophic lateral sclerosis patient cope 
with negative emotions, pain, and difficulties that accompany the disease. Furthermore, these findings suggest assessing 
resilience in amyotrophic lateral sclerosis patients to better characterise the risk of mood disorders and direct mental health 
screening efforts.
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Badania dotyczące stwardnienia zanikowego bocznego często skupiają się na czysto medycznych aspektach choroby i nie 
uwzględniają doświadczeń i trudności, z jakimi pacjenci borykają się na co dzień. Celem niniejszego badania było opisanie 
rezyliencji (prężności psychicznej) oraz zbadanie jej związku z dobrostanem psychicznym, mierzonym występowaniem 
depresji i lęku w grupie dorosłych chorych na stwardnienie zanikowe boczne o różnym stopniu nasilenia. Metody: Autorzy 
prowadzili przekrojowe badanie na Sardynii (Włochy) w okresie od stycznia do czerwca 2017 roku. Do badania włączono 
31 osób ze stwardnieniem zanikowym bocznym (mężczyźni: 55%, średnia wieku: 63,8 roku, odchylenie standardowe: 9,6), 
przebywających w jednym z głównych lokalnych ośrodków zajmujących się leczeniem stwardnienia zanikowego bocznego. 
Wiek pacjentów, reprezentujących całą populację chorych w omawianym regionie, mieścił się w przedziale od 37 do 81 lat 
(M  =  63,81; SD  =  9,63). Z pomocą personelu uczestnicy badania uzupełnili skalę rezyliencji Connor–Davidsona 
(Connor–Davidson Resilience Scale) oraz Szpitalną Skalę Lęku i Depresji (Hospital Anxiety and Depression Scale). 
Wyniki: Stwierdzono istotną, silnie ujemną korelację między rezyliencją a dobrostanem psychicznym. Ponadto 
zaobserwowano spadek nasilenia depresji wraz z upływem czasu od rozpoznania choroby oraz jej wzrost wraz z wiekiem 
pacjenta. Wnioski: W świetle uzyskanych wyników można przyjąć hipotezę, iż odpowiednie wsparcie psychologiczne 
sprzyjające aktywacji zasobów rezyliencji może pomóc chorym na stwardnienie zanikowe boczne w radzeniu sobie 
z negatywnymi emocjami, bólem i trudnościami towarzyszącymi tej chorobie. Ponadto uzyskane wyniki wskazują na 
potrzebę oceny rezyliencji u osób ze stwardnieniem zanikowym bocznym w celu lepszej charakterystyki ryzyka wystąpienia 
zaburzeń nastroju oraz odpowiedniego ukierunkowania badań przesiewowych w zakresie zdrowia psychicznego.
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What is already known about this topic
• Different research has studied resilience in amyotrophic 
lateral sclerosis (ALS) caregivers.
• Little is known regarding resilience in ALS patients.
What this paper adds
• Given that resilience represents one of the patient’s most 
important resources, this research offers a comprehen-
sive overview on resilience in a sample of ALS patients.
• Resilience was analysed in a relationship with depression, 
anxiety as well as clinical and demographic variables.
• We also analysed the role of resilience and psychologi-
cal well-being among patients at different stages of the 
disease.
Various research studies in the field of psycholo-gy have investigated different aspects of patholo-gy and its impact on patients and their loved ones. 
The area most commonly investigated in ALS patients at the 
psychological level is the construct of quality of life (QoL). 
The psychological component of this dimension, particular-
ly in a degenerative pathology such as ALS, is very important 
(Pagnini, 2013). Anxiety and depression have been investi-
gated most thoroughly as they threaten psychological well-
being (Lulé et al., 2008). Studies have shown that anxiety is 
significantly higher in the diagnosis phase, not connected in 
a decisive way to the pathology as such, and positively cor-
related with depression, the rapid progression of pathology, 
and low life satisfaction (Vignola et al., 2008). Other stud-
ies observed that the level of depression is highly signifi-
cant in predicting patients’ mortality and is positively cor-
related with a high level of pathology severity, particularly 
in the initial stage of ALS (CD-RISC: Home, 2016). A study 
conducted by Lulé et al. (2008) found a significant negative 
correlation between patients’ education level and the grav-
ity of their depressive symptoms; this is probably due their 
greater ability to develop coping strategies compared to pa-
tients with lower education.
Resilience can be considered as a combination of per-
sonality traits and physiological characteristics (Thakore 
and Pioro, 2016), and it is referred to as the capability of 
a strained body to recover and adapt its size and shape after 
alterations caused by stressor events (Zani and Cicognani, 
2008). It is well known how important resilience is in in-
fluencing psychological well-being, and this influence has 
been widely demonstrated in both normative and clinical 
populations (CD-RISC: Home, 2016). In particular, litera-
ture shows the positive effects of resilience on anxiety and 
depression in individuals affected by serious diseases, such 
as multiple sclerosis (Black and Dorstyn, 2015).
To our knowledge, most research has focused on resilience 
in ALS caregivers, and only a few studies have investigated 
resilience in ALS patients (Hogg et al., 1994; Rabkin et al., 
2000; Tedman et al., 1997). However, it was not their prima-
ry focus and they did not employ validated instruments to 
measure the construct. Given that resilience represents one 
of the patient’s most important resources, which is of great 
value for a successful psychological intervention, we decid-
ed to address this gap in the literature. Hence, the aims of 
the present study were to describe resilience in a sample 
of ALS patients and analyse its relationship with depres-
sion, anxiety as well as clinical and demographic variables. 
Our further aim was to investigate the possible changes in 
the role of resilience at different stages of the disease by as-
sessing the presence of differences in the strength of the link 
between resilience (both overall and subdimensions) and 
psychological well-being among patients at different stag-
es of the disease.
METHODS
Participants
This was a cross-sectional study conducted in Sardinia 
(Italy). The study took place between January 2017 and 
June 2017. A total of 31 ALS patients living in the Italian 
region of Sardinia, including 55% of males (males: 17; fe-
males: 14), were included in the study. They were recruit-
ed from one of the main regional centres for ALS treatment 
on the island, and represented the total population of ALS 
patients in the territory in question. The participants were 
asked to take part in the research during their periodical 
medical examination. Questionnaires were administered at 
patients’ homes by trained psychologists. The age of patients 
ranged from 37 to 81 years (M = 63.81; standard deviation, 
SD = 9.63), while the average time after a definite ALS diag-
nosis was 4.45 years (SD = 3.14). As for the education lev-
el, eight patients finished primary school, twelve had mid-
dle school education, five had high school education, and 
five declared a degree. One participant was illiterate. All pa-
tients were classified according to King’s clinical staging sys-
tem (Balendra et al., 2015) based on the assessment of se-
quential clinical milestones in ALS progression. Six patients 
were classified as stage 1 (i.e. symptom onset, functional in-
volvement of one central nervous system region); 5 as stage 
2 (i.e. involvement of two central nervous system regions); 
5 as stage 3 (i.e. three regions involved); and 15 as stage 4. 
Informed consent was obtained from each participant in-
cluded in the study.
Instruments
The Connor–Davidson Resilience Scale (CD-RISC) 
(Connor and Davidson, 2003; Italian version: Di Fabio 
and Palazzeschi, 2012) is a tool developed to quantify re-
silience in clinical patients using a short self-assessment 
scale. It is composed of 25 items on a 5-point Likert scale 
(0 = “not at all true”; 4 = “nearly always true”), and compris-
es 5 subscales: Personal Competence, Tolerance to Negative 
Affect, Positive Acceptance, Personal Control, and Spiritual 
Orientation. The overall resilience score is a sum of re-
sponses to all the items (range: 0–100). The scale has been 
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translated into different languages, including the Italian ver-
sion used in this study, and all versions have demonstrat-
ed validity and reliability of the CD-RISC, as well as excel-
lent internal coherence, with a Cronbach’s alpha between 
0.82 and 0.93 in various research studies (CD-RISC: Home, 
2016). In this study, the Cronbach’s alpha value for overall 
reliability was 0.93. The subscales’ Cronbach’s alpha values 
ranged from 0.60 to 0.89.
The Hospital Anxiety and Depression Scale (HADS) 
(Zigmond and Snaith, 1983) is a short self-assessment test 
designed to measure anxiety and depression, which “are not 
seen in a specifically clinical perspective, but as the intrinsic 
components of the experience of illness,” in patients affect-
ed by organic pathologies (Fossati and Marzocchi, 2008). 
The HADS is composed of 14 items assessed on a 4-point 
Likert scale (from 0 to 3) and contains 2 subscales: Anxiety 
and Depression. The study used the Italian version of the 
tool (Costantini et al., 1999), validated in a study conduct-
ed in cancer patients, which showed its good reliability 
(Cronbach’s alpha for the depression dimension = 0.71, and 
for anxiety = 0.86). The Cronbach’s alpha values for this 
study were 0.87 and 0.82 for anxiety and depression scales, 
respectively.
Data analysis
As a first step, we computed descriptive statistics for all 
study variables, namely anxiety and depression, overall re-
silience, and resilience subscales, and tested for the presence 
of differences in depression, anxiety and resilience linked 
to socio-demographic variables, using one-way ANOVA. 
For resilience dimensions, we performed a one-way with-
in-subjects ANOVA to test for the presence of significant 
differences among subscales. The levels of resilience at dif-
ferent stages of the disease were reported, testing for possi-
ble differences using a one-way between-subjects ANOVA. 
Thereafter, in order to investigate the relationships between 
resilience and other study variables, Spearman’s correlations 
were calculated among the CD-RISC overall and subscale 
scores as well as depression and anxiety, demographics, and 
clinical variables (i.e. time from diagnosis). The relationship 
between resilience and ALS stage was analysed with a one-
way ANOVA using the ALS stage as a predictor and the 
CD-RISC scores as dependent variables. Lastly, using the 
Fisher’s Z test, we tested for the presence of significant dif-
ferences in the strength of correlations between resilience 
and depression and anxiety among patients at different stag-
es of the disease.
RESULTS
Tab. 1 shows the descriptive statistics related to the study 
variables and normative values for the general Italian pop-
ulation. We performed a repeated measure ANOVA to test 
for the presence of significant differences among different 
resilience subscales. No significant differences emerged, 
with Wilk’s Lambda = 0.83, F(4, 27) = 1.35, and p = 0.28. 
In terms of the effects of disease stage on resilience, we per-
formed a one-way ANOVA for the overall resilience and 
for each of the resilience subscales (descriptive statistics by 
ALS stage are reported in Tab. 2). No significant differenc-
es emerged. The scores obtained for the anxiety subscale in 
the HADS showed no anxiety in 48% of the participants, 
mild to severe anxiety in the remaining 52%; 65% of pa-
tients did not present depressive symptomatology, while the 
others had mild to moderate depression and there were no 
patients with severe depression.
Tab. 3 shows significant correlations, which were nega-
tive between resilience (overall and subscales) and anxiety 
and depression, positive between depression and anxiety, 
positive between anxiety and depression and patient age, 
and negative between time from diagnosis and depression. 
The strength of these correlations ranged from moder-
ate to strong; the strongest relationship was found be-
tween anxiety and depression. In the CD-RISC subscales, 
Study sample General population 
Min Max M SD M SD
HADS
Anxiety 1 18 8.26 4.91 7.6 4.4
Depression 0 14 5.68 4.45 5.4 4.0
CD-RISC
Overall resilience 27 92 60.48 19.06 74.16 9.99
Personal competence 0.63 4.00 2.55 0.96
Tolerance negative affect 0.57 3.57 2.27 0.80
Positive acceptance 0.60 4.00 2.45 0.87
Personal control 0.33 4.00 2.48 1.04
Spiritual orientation 0.50 4.00 2.23 1.06
Note: General population norms are reported when available.
Tab. 1.  Descriptive statistics of study variables
Stage 1 Stage 2 Stage 3 Stage 4
M SD M SD M SD M SD
HADS
Anxiety 9.25 4.99 8.33 7.09 6.33 4.16 8.33 4.99
Depression 5.50 2.89 4.67 5.51 4.67 2.08 6.00 4.96
CD-RISC
Overall 
resilience 67.50 12.82 57.00 30.05 57.00 22.54 60.14 19.11
Personal 
competence 3.03 1.12 2.33 1.20 2.46 1.30 2.51 0.91
Tolerance 
negative 
affect
2.39 0.07 2.29 1.27 2.05 1.09 2.28 0.82
Positive 
acceptance 2.70 0.68 2.07 1.22 2.40 0.40 2.47 0.93
Personal 
control 2.92 0.74 2.44 1.50 2.11 1.26 2.46 1.05
Spiritual 
orientation 2.13 0.48 2.33 1.04 2.33 1.76 2.21 1.11
Tab. 2.  Descriptive statistics of outcome variables by ALS stage
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a strong positive correlation was found between the vari-
ous dimensions and the total score, and there was a mod-
erate negative correlation between the subscales and the 
patients’ anxiety and depression levels; the only excep-
tion was Spiritual Orientation, which revealed a non-sig-
nificant correlation. For education level, none of the vari-
ables in the study showed significant differences, with the 
only exception being depression, which was significant-
ly higher among individuals with lower education levels 
(F(3, 27) = 5.23, p = 0.04). Lastly, for the clinical variables, 
there were no significant associations between resilience 
and time from diagnosis (r ≤ 0.20, p > 0.05) or the stage 
of the disease, as defined by King’s system (F(3, 27) ≤ 0.39, 
p > 0.05). Furthermore, no significant differences (p > 0.05) 
were found in the strength of correlation between resilience 
dimensions and depression and anxiety among patients at 
different stages of the disease.
DISCUSSION
ALS patients show significantly higher anxiety and depres-
sion compared with the general population. The data ob-
tained showed that the percentage of patients with moder-
ate-to-severe depressive symptoms was lower than in other 
research studies conducted previously using the same in-
struments to study ALS patients (p < 0.05). Indeed, 19% 
of cases in our sample scored over 11 points in contrast to 
44% reported by Hogg et al. (1994) and 35% reported by 
Tedman et al. (1997). As for resilience, we found that its 
levels in ALS patients in our sample are on average signifi-
cantly lower than those reported for a healthy population in 
Italy, t(67) = 3.61, p < 0.001 (Ghisi et al., 2013). This is not 
surprising, and it is in line with literature investigating re-
silience in clinical populations. More specifically, we found 
that all resilience dimensions (i.e. Personal Competence, 
Tolerance to Negative Affect, Positive Acceptance, Personal 
Control, and Spiritual Orientation) were strongly corre-
lated, among other things, with the exception of Spiritual 
Orientation, which appeared to be not related to other re-
silience components. This was probably due to the specific-
ity of the spiritual and religious ways of dealing with stress-
ful events. Thus, the role of religiosity and spirituality in 
dealing with illness should be studied in more detail. In our 
sample, no differences in resilience dimensions were found; 
this could be due to the specificity of the sample, the salient 
features of the disease, or the characteristics of the Italian 
version of the CD-RISC. Moreover, both overall resilience 
and the dimensions of resilience were not affected by the 
stage of ALS, thus leading us to believe that resilience is 
not linked to the purely physical impairment involved in 
the disease.
The results of the present study revealed that a strong rela-
tionship exists between negative emotions in ALS and pro-
tector factors tied to individual resilience resources, which 
can help in coping. In view of the strong negative correla-
tion between total CD-RISC scores and the levels of anxi-
ety and depression in the sample, we could hypothesise that 
the low level of resilience in ALS patients is responsible for 
the higher level of negative emotions. On the other hand, 
the significant negative correlation between the CD-RISC 
subscales (except for Spiritual Orientation) and the HADS 
scores could suggest that anxiety and depression cause an 
inhibition of some components of resilience, which are 
therefore lower in patients with higher HADS scores. It is 
also possible that some sort of circular reaction is triggered, 
meaning that low resilience leads to an increase in anxi-
ety and depression, which in turn increasingly inhibit the 
patient’s remaining resilience resources (which would ex-
plain the difference from the average healthy population 
and the negative correlation). However, this is not certain 
since there is no data on the resilience in each patient in the 
period preceding the disease.
As for resiliency, we did not find a correlation between ALS 
stages and the levels of anxiety and depression; this could 
confirm the fact that in a disease such as ALS, the individu-
al’s well-being is not determined by the physical domain of 
1 2 3 4 5 6 7 8 9 10
CD-RISC
1. Overall resilience
2. Personal competence 0.918**
3. Tolerance negative affect 0.863** 0.701**
4. Positive acceptance 0.891** 0.745** 0.702**
5. Personal control 0.863** 0.777** 0.707** 0.717**
6. Spiritual orientation 0.273 0.098 0.085 0.341 0.119
HADS
7. Anxiety −0.576** −0.507** −0.478** −0.641** −0.504** −0.015
8. Depression −0.699** −0.619** −0.569** −0.664** −0.595** −0.294 0.815**
9. Gender −0.231 −0.222 −0.253 −0.237 −0.217 0.207 0.354 0.244
10. Age −0.110 −0.088 −0.224 0.012 −0.068 0.004 0.362* 0.445* 0.190
11. Time from diagnosis 0.036 −0.011 −0.028 0.133 −0.025 0.203 −0.310 −0.392* 0.014 −0.168
* p < 0.05, ** p < 0.001.
Tab. 3.  Pearson’s correlations (r) between resilience, anxiety, depression, gender, age, and time from diagnosis
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life, but explained by the various dimensions of resilience.
Moreover, the analysis of the link between each patient’s 
clinical information and the scores in the two tests revealed 
a negative relationship between the time from diagnosis and 
depression, suggesting that the initial negative reaction to 
the discovery of the disease later becomes a more function-
al response focusing on adapting to the situation, as in line 
with previous studies (Hillemacher et al., 2004). This find-
ing contradicts previous research findings that highlighted 
the presence of a positive correlation between depression 
and disease duration. A more in-depth study could be use-
ful to disambiguate the issue (e.g. by applying a longitudi-
nal design to follow psychological well-being trends start-
ing from the diagnosis).
With regard to the patients’ education level, the strongly 
negative correlation between this variable and depression 
can be seen as a confirmation of the study by Lulé et al. 
(2008) cited above. This is probably because educated par-
ticipants have a greater capacity to trigger adaptive mecha-
nisms in order to cope with depressive experiences. In ad-
dition, the positive correlation between participant age and 
the level of anxious-depressive symptomatology could be 
explained by the greater ability of younger participants to 
develop coping strategies to deal with the negative experi-
ences related to the illness.
Study limitations include a small sample size and possible 
bias, since this was not a random sample. The geographic 
provenance of participants is very homogeneous and this 
could represent a limitation to the generalisability of results; 
further studies recruiting more subjects from different re-
gions/areas are needed to confirm our findings.
On the whole, our findings have relevant implications: the 
influence of resilience on individual competence in dealing 
with the disease indicates the need to identify factors linked 
to different levels of resilience. Furthermore, specific inter-
ventions could be developed to improve or consolidate in-
dividual’s resilience during disease progression.
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